Managers’ transactions
May 25 2023 - 4:31AM
Managers’ transactions
May 25,2023
Announcement no. 32
Managers’
transactions
Pharma Equity Group A/S has today
received notification pursuant to article 19 of Regulation (EU) no.
596/2014 of the below transactions related to shares in Pharma
Equity Group A/S made by persons discharging managerial
responsibilities in Pharma Equity Group and/or persons closely
related with them.
1. Details of the person discharging
managerial responsibilities/person closely
associated |
a) Name |
Thomas Kaas Selsø |
2. Reason for the notification |
a) Position/status |
CEO |
b) Initial notification/amendment |
Initial notification |
3. Details of the issuer |
a) Name |
Pharma Equity Group A/S |
b) LEI |
2138008SUI4D917FKN20 |
c) Trade name |
PEG |
4. Details of the transaction(s) |
a) Description of the financial instrument,
type of instrument and Identification code |
Shares, ISIN code DK0061155009 |
b) Nature of the transaction |
Purchase |
c) Price(s) and volume(s) |
Price: DKK 167,225Volume: 551,724 |
d) Aggregated information - Aggregated
volume - Aggregated price |
N/A |
e) Date of the transaction |
25-05-2023, 09:26 CEST |
f) Place of the transaction |
Nasdaq Copenhagen A/S |
For further information, please
contact:
Thomas Kaas Selsø, CEO of Pharma
Equity Group A/S, phone: 40 22 21 14
Peter M. Eriksen, Chair of the Board
of Directors of Pharma Equity Group A/S, phone: 51 99 66
00.
Pharma Equity Group A/s (LSE:0REU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pharma Equity Group A/s (LSE:0REU)
Historical Stock Chart
From Jul 2023 to Jul 2024